TSE: 4599 - StemRIM

Yield per half year: -18.86%
Sector: Healthcare

StemRIM

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
340.98 111.03 207.1% 241.92 +40.95%
P/S 24.43 75.03 -67.44%
P/BV 5.54 70.29 -92.12%
P/FCF 54.4 80.52 -32.44%
Ev/Ebitda 244.69 76.71 218.99%
Ev/S 20.08 72.43 -72.28%
Ev/FCF 41.57 15.5 168.28%
E/P 0.0027 0.1179 -97.71%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
3/10
8.21 -78.2 -110.49% -1820.35 -100.45%
ROE 1.62 -10.46 -115.53%
ROA 1.57 -10.03 -115.67%
ROIC 0 9.09 -100%
ROS 7.16 -143.89 -104.98%
ROCE 1.4 2.34 -40.32%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0028 1.08 -99.74% 0.0035 -21.09%
Nеt Debt/Ebitda -52.98 -0.3908 13456.14%
Debt/Ratio 5.0E-5 0.1308 -99.96%
Debt/Equity 0.0023 6.92 -99.97%
Debt/Net Income 0.0032 -1.84 -100.17%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.62 -100% 0 0%
Number of years of dividend growth 0 1.16 -100%
DSI 0 0.7238 -100%
Average dividend growth 0 -10.93 -100%
Average percentage for 5 years 0 1.88 -100%
Average percentage for payments 1.87 37.94 -95.08%
Difference from average difference in sector -2.62

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
2250 170.19 1222.05%
Growth impulse Ebitda in 5 years -126.76 101.21 -225.24%
Growth impulse Net Income in 5 years -123.34 82.55 -249.41%
Growth impulse FCF in 5 years -244.8 104.08 -335.2%
Growth impulse EPS in 5 years -115.98 127.91 -190.67%
IP Score
3.35/10

Similar companies

Taisho Pharmaceutical Holdings Co., Ltd.

Eisai Co., Ltd.

COSMOS Pharmaceutical Corporation

Astellas Pharma Inc.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription